Versant Venture Capital VII, L.P.
CIK 1750266 · last filed 2025-09-22
Versant Venture Capital VII, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $51.4M of LENZ on Sep 22, 2025. Across all open-market trades the lifetime net is −$179.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.95M
2
3
-$179.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LENZ | 10%+ Owner | 2,060,248 | $6.77 | $13.95M | -$143.73M | 2 | 2025-09-22 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | 10%+ Owner | 4,867,172 | $40.39 | $196.59M | -$35.70M | 1 | 2021-08-31 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-22 | LENZ | Sell (S) | −1,217,736 | -$51.43M | EDGAR |
| 2025-08-19 | LENZ | Sell (S) | −2,346,417 | -$92.30M | EDGAR |
| 2021-08-31 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Sell (S) | −2,550,000 | -$35.70M | EDGAR |